Baird analyst David Rescott raised the firm’s price target on Medtronic (MDT) to $91 from $90 and keeps a Neutral rating on the shares. The ...

Medtronic on Tuesday missed Wall Street estimates for third-quarter revenue due to lower purchases of its surgical devices by ...

Medtronic posted a strong profit for Q3 of fiscal year 2025, though shares were down as its cardiac ablation product success ...

Medtronic's stock has been static, not delivering any gains for investors. Click here to find out why MDT stock is a Buy.

CEO Geoff Martha said Medtronic would submit its application for urological procedures to the Food and Drug Administration by ...

Third-quarter results for Medtronic (NYSE:MDT) included a timeline for a planned label expansion for its automated insulin ...

While this is a fun, satisfying sight to behold, it's unfortunately temporary. Known as a muscle pump, this type of instant muscle growth occurs for a reason. But does it actually have any ...

Shares of Medtronic are benefiting from an improved ... And in the highly competitive diabetes care segment, the new MiniMed 780G insulin pump system employs AI algorithms to predict and ...

In this article, we are going to take a look at where Medtronic plc (NYSE:MDT) stands against the other stocks on Jim Cramer's radar. Jim Cramer, host of Mad Money, recently emphasized the ...

Medtronic hired a new chief financial officer away from French carmaker Renault. Thierry Pieton, chief financial officer of Renault Group since March 2022, will take on the CFO role starting March ...

Parkhill's exit came months after Medtronic, as part of a turnaround, decided to exit its unprofitable ventilator product line within its patient monitoring and respiratory interventions (PMRI ...